SEC Form D · filed January 8, 2024
Centrexion Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Joseph R. Swedish · Boston, MADirectorSol J. Barer, Ph.D · Boston, MADirectorJ.C. J. Lopez, M.D · Boston, MADirectorRandall M. Stevens · Boston, MAExecShawn R. Tomasello · Boston, MADirectorJeffrey B. Kindler · Boston, MAExec · DirectorJames N. Campbell, M.D · Boston, MAExec · DirectorColin J. Hill · Boston, MADirectorMichael J. Ward · Boston, MAExecDaniel M. Agostino · LONDON, United KingdomDirectorPaul R. Malan · LONDON, United KingdomExec · DirectorFarooq Abbasi · New York, NYDirectorDeryk I. King · LONDON, United KingdomDirectorHealthTronics Stone Solutions LLC · Round Rock, TXDirectorAlcides Ferreira · Dayton, OHExecChuck Templeton · CHICAGO, ILExec · DirectorGiovanni J. Maso · New York, NYExecIain R. Macleod · LONDON, United KingdomDirectorJean-Francois Clavier · San Francisco, CAExec · DirectorAndrew Mcloughlin · San Francisco, CADirectorHershel Mehta · La Habra, CADirectorTomaz Strgar · Sentjernej, 2AExec · DirectorJason Long · La Jolla, CADirectorHongliang Zhou · Denver, CODirectorBrandon M. Levitan · CHICAGO, ILExecGeorge Athanasiadis · San Juan, Puerto RicoDirectorAllen Kurt · VANCOUVER, British Columbia, CanadaExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗